David W. Lam
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Genetics top 10%
- Diabetes and associated disorders
- Inflammatory Bowel Disease
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 9
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
- Surgery 8
- Pancreatic function and diabetes 5
- Pancreatitis Pathology and Treatment 2
- Co-authors
- Derek LeRoith (1 shared paper)Michael S. Bronze (1 shared paper)Tauseef Ali (1 shared paper)Mary Beth Humphrey (1 shared paper)Carol J. Levy (8 shared papers)Bruce A. Buckingham (6 shared papers)Camilla Levister (7 shared papers)Timothy S. Bailey (2 shared papers)
- Journals
- Diabetes Technology & Therapeutics (3 papers)Diabetes (3 papers)Diabetes Care (2 papers)American Journal of Nephrology (1 paper)Journal of Diabetes Science and Technology (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
David W. Lam
23 papers receiving 878 citations
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 410
- Genetics 269
- Orthopedics and Sports Medicine 60
- Surgery 296
- Internal Medicine 22
Countries citing papers authored by David W. Lam
This map shows the geographic impact of David W. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Lam more than expected).
Fields of papers citing papers by David W. Lam
This network shows the impact of papers produced by David W. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Lam. The network helps show where David W. Lam may publish in the future.
Co-authors
The 25 scholars most cited alongside David W. Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 260 | |
| 2 | 2009 | 210 | |
| 3 | 2018 | 105 | |
| 4 | 2017 | 75 | |
| 5 | 2018 | 59 | |
| 6 | Ferritin release by mononuclear cells in hereditary hemochromatosis. | 1989 | 30 |
| 7 | 2017 | 29 | |
| 8 | 2021 | 26 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2018 | 16 | |
| 12 | 2023 | 15 | |
| 13 | 2017 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 3 | |
| 17 | 2013 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About David W. Lam
David W. Lam is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Cardiology and Cardiovascular Medicine and Hematology, having authored 24 papers that have together received 903 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers), Pancreatic function and diabetes (5 papers), Diabetes and associated disorders (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers), Metabolism, Diabetes, and Cancer (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (410 citations), Genetics (269 citations), Orthopedics and Sports Medicine (60 citations), Surgery (296 citations) and Internal Medicine (22 citations). David W. Lam has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Derek LeRoith, Michael S. Bronze, Tauseef Ali, Mary Beth Humphrey, Carol J. Levy, Bruce A. Buckingham, Camilla Levister, Timothy S. Bailey, Gregory P. Forlenza and Leslie J. Klaff. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes, Diabetes Care, American Journal of Nephrology and Journal of Diabetes Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.